Research Article
Other versions:
- ContentsContents
- Article InfoArticle Info
- CiteCite
- MetricsMetrics
- CommentComment
- RelatedRelated
- FigsFigs
- TabsTabs
- DataData
- RefsRefs
- CitedCited
In silico and in vitro evaluation of novel carbothioamide-based and heterocyclic derivatives of 4-(tert-butyl)-3-methoxybenzoic acid as EGFR tyrosine kinase allosteric site inhibitors. Results in Chemistry 7: 101329.
DOI: 10.1016/j.rechem.2024.101329
Novel 1,3,4‐oxadiazole derivatives of naproxen targeting EGFR: Synthesis, molecular docking studies, and cytotoxic evaluation. Drug Development Research 85: .
DOI: 10.1002/ddr.22231
New Carbothioamide and Carboxamide Derivatives of 3-Phenoxybenzoic Acid as Potent VEGFR-2 Inhibitors: Synthesis, Molecular Docking, and Cytotoxicity Assessment. Current Cancer Drug Targets 25: 412.
DOI: 10.2174/0115680096307334240429050730
New 4-amino-3-chloro benzoate ester derivatives as EGFR inhibitors: synthesis, in silico and biological analyses. Future Medicinal Chemistry 16: 2647.
DOI: 10.1080/17568919.2024.2431478
Synthesis, In Silico Prediction, and In Vitro Evaluation of Anti-tumor Activities of Novel 4'-Hydroxybiphenyl-4-carboxylic Acid Derivatives as EGFR Allosteric Site Inhibitors. Current Medicinal Chemistry 31: 6336.
DOI: 10.2174/0109298673305163240427065543
Synergistic Proliferation Effects of Xanthohumol and Niflumic Acid on Merkel and Glioblastoma Cancer Cells: Role of Cell Membrane Interactions. International Journal of Molecular Sciences 25: 11015.
DOI: 10.3390/ijms252011015
Performance of Green Desymmetrization Methods toward Bioactive Cephalostatin Analogues. Current Medicinal Chemistry 31: 3327.
DOI: 10.2174/0929867330666230508145058
Novel 5-bromoindole-2-carboxylic Acid Derivatives as EGFR Inhibitors: Synthesis, Docking Study, and Structure Activity Relationship. Anti-Cancer Agents in Medicinal Chemistry 23: 1336.
DOI: 10.2174/1871520623666230227153449
Design, Synthesis, in silico and in vitro Evaluation of New Combretastatin A-4 Analogs as Antimitotic Antitumor Agents. Medicinal Chemistry 19: 1018.
DOI: 10.2174/1573406419666230530155741
Synthesis and in vitro evaluation of new oxadiazole thioethers as antibacterials. Pharmacia 71: 1.
DOI: 10.3897/pharmacia.71.e139122
New Combretastatin Analogs as Anticancer Agents: Design, Synthesis, Microtubules Polymerization Inhibition, and Molecular Docking Studies. Chemistry & Biodiversity 20: .
DOI: 10.1002/cbdv.202201206
New Niflumic Acid Derivatives as EGFR Inhibitors: Design, Synthesis, In silico Studies, and Anti-proliferative Assessment. Medicinal Chemistry 19: 445.
DOI: 10.2174/1573406419666221219144804
Synthesis, characterization, anticancer activity and molecular docking of metal complexes bearing a new Schiff base ligand. Journal of Biomolecular Structure and Dynamics 41: 10969.
DOI: 10.1080/07391102.2023.2191725
DFT, Molecular Docking, Bioactivity and ADME Analyses of Vic-dioxim Ligand Containing Hydrazone Group and its Zn(II) Complex. Current Computer-Aided Drug Design 20: 264.
DOI: 10.2174/1573409919666230503094400
Design, Synthesis, and Molecular Docking Studies of 5‐Bromoindole‐2‐Carboxylic Acid Hydrazone Derivatives: In Vitro Anticancer and VEGFR‐2 Inhibitory Effects. ChemistrySelect 7: .
DOI: 10.1002/slct.202203726
Advances in VEGFR Inhibitors: A Comprehensive Review of Novel Anticancer Agents. Anti-Cancer Agents in Medicinal Chemistry 25: 663.
DOI: 10.2174/0118715206356712241202112641
Subscribe to email alerts for current Article's categories